InvestorsHub Logo
Followers 3
Posts 793
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Wednesday, 02/24/2021 11:28:11 AM

Wednesday, February 24, 2021 11:28:11 AM

Post# of 8493
Maybe it has to do with this:

NIH is recommending Lilly's newly authorized infused antibody cocktail of bamlanivimab plus etesevimab for COVID outpatients with mild-to-moderate disease at risk of progressing to severe disease.

Enhanze to the rescue

https://www.covid19treatmentguidelines.nih.gov/statement-on-bamlanivimab-plus-etesevimab-eua/?utm_campaign=+46344713&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News